Researchers at the Mayo Clinic Cancer Center have found that the drug adagrasib could be helpful in the treatment of gastrointestinal cancers, according to a Feb. 7 Mayo Clinic News Network article.
Promising gastrointestinal cancer treatment emerges for those with highest risk
